https://www.phcoker.com/product/282526-98-1/
Cetilistat is a novel pancreatic lipase inhibitor developed by Alizyme for the treatment of obesity and diabetes and other diseases. It acts by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the gut. Prevents fat (triglycerides) in food from being metabolized and converted into free fatty acids that can be absorbed by the body. Cetilistat significantly reduced weight with and was better tolerated than orlistat.
info@phcoker.com